Pemetrexed Plus Gemcitabine in Renal Cell Cancer

Clinical trial NCT00491075 · TERMINATED

Trial details

NCT number: NCT00491075
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2005-12-01
Primary completion: 2011-09-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.